Paget's Disease Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Clinical Trials
• Forums

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Conditions:   Paget's Disease of the Bone;   HypocalcemiaInterventions:   Drug: Reclast (ZOL446, zoledronic acid);   Dietary Supplement: Calcium;   Dietary Supplement: Vitamin DSponsors:   Novartis;   Novartis PharmaceuticalsCompleted - verified March 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2008 Category: Research Source Type: clinical trials

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Conditions:   Paget's Disease of the Bone;   HypocalcemiaIntervention:   Drug: ZOL446Sponsors:   Novartis;   Novartis PharmaceuticalsCompleted - verified February 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2008 Category: Research Source Type: clinical trials

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Conditions:   Paget's Disease of the Bone;   HypocalcemiaInterventions:   Drug: Reclast (ZOL446, zoledronic acid);   Dietary Supplement: Calcium;   Dietary Supplement: Vitamin DSponsors:   Novartis;   Novartis PharmaceuticalsCompleted - verified March 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2008 Category: Research Source Type: clinical trials

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Conditions:   Paget's Disease of the Bone;   HypocalcemiaIntervention:   Drug: ZOL446Sponsors:   Novartis;   Novartis PharmaceuticalsRecruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2008 Category: Research Source Type: clinical trials